Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.2.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net earnings, including noncontrolling interest $ 168,105 $ 285,442 $ 263,099
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 111,711 107,238 101,069
Costs recognized on sale of acquired inventory 729 400 1,596
Deferred income taxes (39,447) (29,567) 6,816
Stock-based compensation expense 38,042 39,230 42,183
Fair value adjustment to contingent consideration payable (3,500) (12,100) (20,400)
Contingent consideration payments - operating     (3,300)
Gain on sale of CCXI investment   (37,176)  
Fair value adjustment on available-for-sale investments (283) (472) (15,002)
Loss on equity method investment 6,841 1,143  
Asset impairment restructuring 2,634   546
Eminence impairment     18,715
Gain on sale of Eminence   (11,682)  
Leases, net 1,708 2,059 (1,201)
Impairment of assets held-for-sale 21,963    
Other operating activity 584 455 668
Change in operating assets and operating liabilities, net of acquisition:      
Trade accounts and other receivables, net (20,533) (20,867) (57,596)
Inventories (14,215) (30,167) (32,007)
Prepaid expenses (3,146) (4,585) (3,082)
Trade accounts payable, accrued expenses, contract liabilities, and other 25,769 (7,908) 12,741
Salaries, wages and related accruals 12,618 (24,558) 7,760
Income taxes payable (10,599) (2,492) 2,667
Net cash provided by (used in) operating activities 298,981 254,393 325,272
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from sale of available-for-sale investments 28,083 35,236 26,055
Purchases of available-for-sale investments (5,526) (20,500) (52,998)
Proceeds from sale of CCXI investment   73,219  
Additions to property and equipment (62,877) (38,244) (44,908)
Acquisitions, net of cash acquired (169,707) (101,184)  
Distributions from (Investments in) Wilson Wolf 6,997 (232,000)  
Proceeds from sale of Eminence   17,824  
Investment of forward purchase contract     (25,000)
Net cash provided by (used in) investing activities (203,030) (265,649) (96,851)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Cash dividends (50,419) (50,285) (50,185)
Proceeds from stock option exercises 60,935 29,813 77,155
Re-purchases of common stock (80,042) (19,562) (160,950)
Borrowings under line-of-credit agreement 225,000 619,661 90,000
Repayments of long-term debt (256,000) (525,661) (175,500)
Contingent consideration payments - financing     (700)
Taxes paid on RSUs and net share settlements (21,872) (28,893) (23,461)
Other financing activity   (2,457) 788
Net cash provided by (used in) financing activities (122,398) 22,616 (242,853)
Effect of exchange rate changes on cash and cash equivalents (2,333) (3,356) (12,092)
Net change in cash and cash equivalents (28,780) 8,004 (26,524)
Cash and cash equivalents at beginning of period 180,571 172,567 199,091
Cash and cash equivalents at end of period 151,791 180,571 172,567
Supplemental disclosure of cash flow information:      
Cash paid for interest $ 14,502 $ 8,368 $ 11,027